R
Richard H. Mattson
Researcher at Yale University
Publications - 194
Citations - 18563
Richard H. Mattson is an academic researcher from Yale University. The author has contributed to research in topics: Epilepsy & Anticonvulsant. The author has an hindex of 71, co-authored 190 publications receiving 17901 citations. Previous affiliations of Richard H. Mattson include United States Department of Veterans Affairs & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures
Richard H. Mattson,Joyce A. Cramer,Joseph F. Collins,Dennis B. Smith,Antonio V. Delgado-Escueta,Thomas R. Browne,Peter D. Williamson,David M. Treiman,James O. McNamara,Charlotte B. McCutchen +9 more
TL;DR: Overall, carbamazepine and phenytoin are recommended drugs of first choice for single-drug therapy of adults with partial or generalized tonic-clonic seizures or with both.
Journal ArticleDOI
How Often Is Medication Taken as Prescribed?: A Novel Assessment Technique
TL;DR: Using a new method with epilepsy as a model, compliance with long-term medications among newly treated and long- term patients is assessed using standard pill bottles with micro-processors in the cap to record every bottle opening as a presumptive dose.
Journal ArticleDOI
Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination
Jacqueline A. French,Peter D. Williamson,Vijay M. Thadani,Terrance M. Darcey,Richard H. Mattson,Richard H. Mattson,Susan S. Spencer,Susan S. Spencer,Dennis D. Spencer,Dennis D. Spencer +9 more
TL;DR: There is a very strong relationship between complicated febrile seizures during early childhood or infancy and the later development of medial temporal lobe epilepsy, which can be a progressive disease as evidenced by silent intervals and progressive elaboration of seizures.
Journal ArticleDOI
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
Tracy A. Glauser,Elinor Ben-Menachem,Blaise F. D. Bourgeois,Avital Cnaan,David Chadwick,Carlos A. M. Guerreiro,Reetta Kälviäinen,Richard H. Mattson,Emilio Perucca,Torbjörn Tomson +9 more
TL;DR: In this article, a 10-member subcommission of the Commission on Therapeutic Strategies of The International League Against Epilepsy (ILAE) evaluated available evidence found through a structured literature review including MEDLINE, Current Contents and the Cochrane Library for all applicable articles from 1940 until July 2005.
Journal ArticleDOI
A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group
TL;DR: Valproate is as effective as carbamazepine for the treatment of generalized tonic-clonic seizures, but carbamazetine provides better control of complex partial seizures and has fewer long-term adverse effects.